4.7 Article

Candida auris in Healthcare Facilities, New York, USA, 2013-2017

期刊

EMERGING INFECTIOUS DISEASES
卷 24, 期 10, 页码 1816-1824

出版社

CENTERS DISEASE CONTROL
DOI: 10.3201/eid2410.180649

关键词

-

资金

  1. Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement [NU50CK000423, CK000423-01S2]
  2. CDC

向作者/读者索取更多资源

Candida auris is an emerging yeast that causes healthcare-associated infections. It can be misidentified by laboratories and often is resistant to antifungal medications. We describe an outbreak of C. auris infections in healthcare facilities in New York City, New York, USA. The investigation included laboratory surveillance, record reviews, site visits, contact tracing with cultures, and environmental sampling. We identified 51 clinical case-patients and 61 screening case-patients. Epidemiologic links indicated a large, inter-connected web of affected healthcare facilities throughout New York City. Of the 51 clinical case-patients, 23 (45%) died within 90 days and isolates were resistant to fluconazole for 50 (98%). Of screening cultures performed for 572 persons (1,136 total cultures), results were C. auris positive for 61 (11%) persons. Environmental cultures were positive for samples from 15 of 20 facilities. Colonization was frequently identified during contact investigations; environmental contamination was also common.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据